pd 98059 has been researched along with Adenoma Sebaceum in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Adenoma Sebaceum: Facial ANGIOFIBROMA in tuberous sclerosis
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mi, R | 1 |
| Ma, J | 1 |
| Zhang, D | 1 |
| Li, L | 1 |
| Zhang, H | 1 |
1 other study available for pd 98059 and Adenoma Sebaceum
| Article | Year |
|---|---|
Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model.
Topics: Animals; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Down-Regulation; Extracellular | 2009 |